Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in

Shu-Shong Hsu1, Chun-Jen Huang, He-Hsiung Cheng

  • 1Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.

Toxicology
|January 16, 2007
PubMed

Insights

Anandamide induces apoptosis in human osteosarcoma cells by increasing intracellular calcium and activating p38 MAPK. This pathway leads to caspase-3 activation and cell death, impacting osteoblast research.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Pharmacology

Background:

  • The role of anandamide in human osteoblast function remains largely uncharacterized.
  • Osteoblasts are crucial for bone formation and remodeling.
  • Understanding cellular responses to anandamide is vital for potential therapeutic applications.

Purpose of the Study:

  • To investigate the effects of anandamide on human osteosarcoma MG63 cell viability, apoptosis, and intracellular signaling pathways.
  • To elucidate the specific mitogen-activated protein kinase (MAPK) pathways involved in anandamide-induced cellular responses.
  • To determine the role of intracellular calcium (Ca2+) in anandamide-mediated effects on osteoblasts.

Main Methods:

  • MG63 cells were treated with varying concentrations of anandamide.
  • Cell viability was assessed using propidium iodide staining.
  • Apoptosis was evaluated by caspase-3 activation assays.
  • Mitogen-activated protein kinase (MAPK) expression (ERK, JNK, p38) was analyzed via immunoblotting.
  • Intracellular Ca2+ ([Ca2+]i) levels were measured.
  • Pharmacological inhibitors (SB203580, PD98059, SP600125) and BAPTA were used to probe signaling pathways.

Main Results:

  • Anandamide (50-200 microM) decreased cell viability and induced apoptosis, evidenced by caspase-3 activation.
  • Anandamide upregulated ERK, JNK, and p38 MAPK expression.
  • SB203580, a p38 MAPK inhibitor, reversed anandamide-induced apoptosis, while PD98059 (ERK) and SP600125 (JNK) did not.
  • Anandamide (1-100 microM) increased intracellular Ca2+ levels, involving both influx and release.
  • Chelation of intracellular Ca2+ with BAPTA inhibited anandamide-induced cell death and p38 MAPK phosphorylation.

Conclusions:

  • Anandamide triggers apoptosis in MG63 osteosarcoma cells through a mechanism involving increased intracellular Ca2+.
  • The observed calcium increase activates p38 MAPK, which subsequently phosphorylates caspase-3, leading to apoptosis.
  • Anandamide's effects are mediated by the p38 MAPK pathway, not ERK or JNK, highlighting a specific signaling cascade in osteosarcoma cells.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...